Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Cervical Cancer

  Free Subscription


Articles published in Int J Gynaecol Obstet

Retrieve available abstracts of 134 articles:
HTML format



Single Articles


    September 2021
  1. DICK A, Holyk T, Taylor D, Wenninger C, et al
    Highlighting strengths and resources that increase ownership of cervical cancer screening for Indigenous communities in Northern British Columbia: Community-driven approaches.
    Int J Gynaecol Obstet. 2021 Sep 8. doi: 10.1002/ijgo.13915.
    PubMed     Abstract available


  2. NKWABONG E, Kengne B, Nkene Mawamba Y, Sando Z, et al
    Influence of the human immunodeficiency virus on cervical precancerous lesions.
    Int J Gynaecol Obstet. 2021;154:540-543.
    PubMed     Abstract available


  3. JELINEK K, Harding L, Briceno R, Li Z, et al
    Prevalence of high-risk human papillomavirus genotypes in two regions of Peru.
    Int J Gynaecol Obstet. 2021;154:544-549.
    PubMed     Abstract available


    August 2021
  4. CHO HW, Hong JH, Lee JK
    Detection of high-risk human papillomavirus infection and treatment of high-grade vaginal intraepithelial neoplasia: A single-institution study.
    Int J Gynaecol Obstet. 2021;154:227-232.
    PubMed     Abstract available


    July 2021
  5. MUNGO C, Randa M, Shauri A, Serem D, et al
    Characteristics, stage at presentation, and status of women with cervical cancer at a major referral center in western Kenya.
    Int J Gynaecol Obstet. 2021 Jul 20. doi: 10.1002/ijgo.13831.
    PubMed     Abstract available


  6. MWANAHAMUNTU M, Kapambwe S, Pinder LF, Matambo J, et al
    The use of thermal ablation in diverse cervical cancer 'screen-and-treat' service platforms in Zambia.
    Int J Gynaecol Obstet. 2021 Jul 1. doi: 10.1002/ijgo.13808.
    PubMed     Abstract available


  7. MAHANDE MJ, Oneko O, Amour C, Pollie M, et al
    Feasibility and acceptability of human papillomavirus self-sampling in a semi-urban area in northern Tanzania.
    Int J Gynaecol Obstet. 2021;154:113-118.
    PubMed     Abstract available


    June 2021
  8. YU Y, Deng T, Gu S
    Minimally invasive surgery and abdominal radical hysterectomy in patients with early-stage cervical cancer: A meta-analysis.
    Int J Gynaecol Obstet. 2021 Jun 24. doi: 10.1002/ijgo.13796.
    PubMed     Abstract available


  9. TREJO MJ, Soliman AS, Chen Y, Kalima M, et al
    Effects of HIV infection on metastatic cervical cancer and age at diagnosis among patients in Lusaka, Zambia.
    Int J Gynaecol Obstet. 2021 Jun 14. doi: 10.1002/ijgo.13784.
    PubMed     Abstract available


    May 2021
  10. SOFTELAND S, Sebitloane MH, Taylor M, Roald BB, et al
    A systematic review of handheld tools in lieu of colposcopy for cervical neoplasia and female genital schistosomiasis.
    Int J Gynaecol Obstet. 2021;153:190-199.
    PubMed     Abstract available


    April 2021
  11. DORJI T, Tshomo U, Gyamtsho S, Tamang ST, et al
    Gender-neutral HPV elimination, cervical cancer screening, and treatment: Experience from Bhutan.
    Int J Gynaecol Obstet. 2021 Apr 30. doi: 10.1002/ijgo.13728.
    PubMed     Abstract available


    March 2021
  12. KEMPER KE, McGrath CJ, Eckert LO, Kinuthia J, et al
    Correlates of cervical cancer screening among women living with HIV in Kenya: A cross-sectional study.
    Int J Gynaecol Obstet. 2021 Mar 30. doi: 10.1002/ijgo.13690.
    PubMed     Abstract available


    February 2021
  13. TANG X, Qiu J, Guo C, Guo J, et al
    A novel prognostic nomogram utilizing the 2018 FIGO staging system for cervical cancer: A large multicenter study.
    Int J Gynaecol Obstet. 2021 Feb 15. doi: 10.1002/ijgo.13644.
    PubMed     Abstract available


  14. MARINGA VD, Chikandiwa A, Gilham C, Mbodi L, et al
    Performance of the Swede score to predict cervical intraepithelial neoplasia in women with HIV-1 in Johannesburg, South Africa.
    Int J Gynaecol Obstet. 2021;152:188-195.
    PubMed     Abstract available


    January 2021
  15. KRAMER J
    Eradicating cervical cancer: Lessons learned from Rwanda and Australia.
    Int J Gynaecol Obstet. 2021 Jan 17. doi: 10.1002/ijgo.13601.
    PubMed     Abstract available


  16. TAMAUCHI S, Kajiyama H, Osuka S, Moriyama Y, et al
    Reduced response to controlled ovarian stimulation after radical trachelectomy: A pitfall of fertility-sparing surgery for cervical cancer.
    Int J Gynaecol Obstet. 2021 Jan 13. doi: 10.1002/ijgo.13529.
    PubMed     Abstract available


  17. CHUNG MH, De Vuyst H, Greene SA, Topazian HM, et al
    Loop electrosurgical excision procedure (LEEP) plus top hat for HIV-infected women with endocervical intraepithelial neoplasia in Kenya.
    Int J Gynaecol Obstet. 2021;152:118-124.
    PubMed     Abstract available


  18. LIU P, Dai E, Li W, He F, et al
    Effect of pre-operative radiotherapy on long-term outcomes among women with Stage IB1 to IIB cervical squamous cell carcinoma.
    Int J Gynaecol Obstet. 2021;152:125-132.
    PubMed     Abstract available


  19. BUSS LF, Levi JE, Longatto-Filho A, Cohen DD, et al
    Attendance for diagnostic colposcopy among high-risk human papillomavirus positive women in a Brazilian feasibility study.
    Int J Gynaecol Obstet. 2021;152:72-77.
    PubMed     Abstract available


  20. LI Y, Wang H, Zhang Y, Jing X, et al
    Correlation between multi-type human papillomavirus infections and viral loads and the cervical pathological grade.
    Int J Gynaecol Obstet. 2021;152:96-102.
    PubMed     Abstract available


  21. YANG Y, Hu T, Ming X, Yang E, et al
    REBACIN(R) is an optional intervention for persistent high-risk human papillomavirus infection: A retrospective analysis of 364 patients.
    Int J Gynaecol Obstet. 2021;152:82-87.
    PubMed     Abstract available


    December 2020
  22. KIM MH, Jung HJ, Park SI, Kim BJ, et al
    Self-obtained vaginal samples for HPV DNA testing to detect HPV-related cervical disease.
    Int J Gynaecol Obstet. 2020 Dec 23. doi: 10.1002/ijgo.13574.
    PubMed     Abstract available


  23. TEIXEIRA JC, Santos DZ, Campos CS, Vale DB, et al
    Cervical cancer in women under 25 years of age and outside the screening age: Diagnosis profile and long-term outcomes.
    Int J Gynaecol Obstet. 2020 Dec 20. doi: 10.1002/ijgo.13553.
    PubMed     Abstract available


  24. SIMELELA PN
    WHO global strategy to eliminate cervical cancer as a public health problem: An opportunity to make it a disease of the past.
    Int J Gynaecol Obstet. 2020 Dec 2. doi: 10.1002/ijgo.13484.
    PubMed    


    November 2020
  25. BHATLA N, Nessa A, Oswal K, Vashist S, et al
    Program organization rather than choice of test determines success of cervical cancer screening: Case studies from Bangladesh and India.
    Int J Gynaecol Obstet. 2020 Nov 18. doi: 10.1002/ijgo.13486.
    PubMed     Abstract available


  26. ROHNER E, Mulongo M, Pasipamire T, Oberlin AM, et al
    Mapping the cervical cancer screening cascade among women living with HIV in Johannesburg, South Africa.
    Int J Gynaecol Obstet. 2020 Nov 14. doi: 10.1002/ijgo.13485.
    PubMed     Abstract available


  27. ALLENDE-PEREZ S, Dominguez-Ocadio G, Velez-Salas V, Isla D, et al
    Snapshot of symptoms of advanced cervical cancer patients referred to the palliative care service in a cancer center in Mexico.
    Int J Gynaecol Obstet. 2020 Nov 13. doi: 10.1002/ijgo.13479.
    PubMed     Abstract available


  28. KUMAR S, Khanduri A, Sidibe A, Morgan C, et al
    Acting on the call: A framework for action for rapid acceleration of access to the HPV vaccination in low- and lower-middle-income countries.
    Int J Gynaecol Obstet. 2020 Nov 13. doi: 10.1002/ijgo.13482.
    PubMed     Abstract available


  29. KENGSAKUL M, Laowahutanont P, Wilailak S
    Experiences in the prevention and screening of cervical cancer within Thailand.
    Int J Gynaecol Obstet. 2020 Nov 12. doi: 10.1002/ijgo.13481.
    PubMed     Abstract available


  30. LINDEQUE G
    A perspective on cervical cancer prevention and screening in Africa.
    Int J Gynaecol Obstet. 2020 Nov 6. doi: 10.1002/ijgo.13476.
    PubMed     Abstract available


  31. SHOU H, Yasuo Y, Yuan S, Lou H, et al
    Association of pretreatment SUVmax of cervix and SCC-antigen with FIGO2018 stage in Stage IIB-IVB squamous cervical cancer and relationship to prognosis.
    Int J Gynaecol Obstet. 2020 Nov 3. doi: 10.1002/ijgo.13465.
    PubMed     Abstract available


  32. DANIEL GO, Musa J, Akindigh TM, Shinku F, et al
    Prevalence and predictors of precancerous cervical lesions among HIV-positive women in Jos, north-central Nigeria.
    Int J Gynaecol Obstet. 2020;151:253-259.
    PubMed     Abstract available


    October 2020
  33. RAWAT A, Sanders C, Mithani N, Amuge C, et al
    Acceptability and preferences for self-collected screening for cervical cancer within health systems in rural Uganda: A mixed-methods approach.
    Int J Gynaecol Obstet. 2020 Oct 31. doi: 10.1002/ijgo.13454.
    PubMed     Abstract available


  34. VALE DB, Teixeira JC, Braganca JF, Derchain S, et al
    Elimination of cervical cancer in low- and middle-income countries: Inequality of access and fragile healthcare systems.
    Int J Gynaecol Obstet. 2020 Oct 31. doi: 10.1002/ijgo.13458.
    PubMed     Abstract available


  35. MAGDI R, Elshafeey F, Elshebiny M, Kamel M, et al
    A systematic review and meta-analysis of diagnostic accuracy of HPV tests for the screening of cervical cancer in low-resource settings.
    Int J Gynaecol Obstet. 2020 Oct 30. doi: 10.1002/ijgo.13455.
    PubMed     Abstract available


  36. OKADOME M, Nagayama R, Shimokawa M, Sonoda K, et al
    Prognosis of bulky pT2b cervical cancer treated by radical hysterectomy comparing adenocarcinoma with squamous cell carcinoma using propensity score matching.
    Int J Gynaecol Obstet. 2020 Oct 29. doi: 10.1002/ijgo.13451.
    PubMed     Abstract available


  37. LAWAL IK, Suleiman AK, Bagudu Z, Kanmodi KK, et al
    Planning and advocating for cervical cancer prevention in Kebbi State, Nigeria: Learning points for the global call to eliminate cervical cancer.
    Int J Gynaecol Obstet. 2020 Oct 8. doi: 10.1002/ijgo.13414.
    PubMed     Abstract available


  38. YIM ET, Rogers TB, Msami K, Calixte R, et al
    Factors related to completion of referral among women with suspected cervical cancer and dysplasia in Tanzania.
    Int J Gynaecol Obstet. 2020 Oct 6. doi: 10.1002/ijgo.13412.
    PubMed     Abstract available


    September 2020
  39. HOQUE MR, Haque E, Karim MR
    Cervical cancer in low-income countries: A Bangladeshi perspective.
    Int J Gynaecol Obstet. 2020 Sep 28. doi: 10.1002/ijgo.13400.
    PubMed     Abstract available


  40. PATABENDIGE M, Wijesinghe RD, Wijesuriya MWAB, Hapuachchige C, et al
    Surgical management of cervical cancer in a resource-limited setting: One year of data from the National Cancer Institute, Sri Lanka.
    Int J Gynaecol Obstet. 2020 Sep 22. doi: 10.1002/ijgo.13384.
    PubMed     Abstract available


  41. MICHAAN N, Laskov I, Aizic A, Brautbar O, et al
    Laparoscopic sentinel lymph node dissection followed by open radical hysterectomy for early stage cervical cancer: A pilot study.
    Int J Gynaecol Obstet. 2020 Sep 22. doi: 10.1002/ijgo.13383.
    PubMed     Abstract available


  42. LAWAL IK, Ibrahim HA, Chikezie PC
    Practical realities in the management of cervical cancer in low-resource settings: The grey area between resource-appropriate and substandard treatment.
    Int J Gynaecol Obstet. 2020 Sep 3. doi: 10.1002/ijgo.13367.
    PubMed     Abstract available


    August 2020
  43. CORRADO G, Mazzara C, Certelli C, Nsubuga JB, et al
    Screening for cervical cancer in Africa: A proposal of a different combination of VIA test and cervical smear in Uganda.
    Int J Gynaecol Obstet. 2020 Aug 19. doi: 10.1002/ijgo.13350.
    PubMed     Abstract available


    July 2020
  44. ORANG'O EO, Emont JP, Ermel AC, Liu T, et al
    Detection of types of HPV among HIV-infected and HIV-uninfected Kenyan women undergoing cryotherapy or loop electrosurgical excision procedure.
    Int J Gynaecol Obstet. 2020 Jul 26. doi: 10.1002/ijgo.13330.
    PubMed     Abstract available


    June 2020
  45. RODRIGUEZ J, Fletcher A, Heredia F, Fernandez R, et al
    Alternative management for gynecological cancer care during the COVID-2019 pandemic: A Latin American survey.
    Int J Gynaecol Obstet. 2020 Jun 11. doi: 10.1002/ijgo.13272.
    PubMed     Abstract available


  46. BOGANI G, Ditto A, Chiappa V, Pinelli C, et al
    Primary conization overcomes the risk of developing local recurrence following laparoscopic radical hysterectomy in early stage cervical cancer.
    Int J Gynaecol Obstet. 2020 Jun 8. doi: 10.1002/ijgo.13260.
    PubMed     Abstract available


    May 2020
  47. ZHAO Y, Li M, Li Y, Lv Q, et al
    Evaluation of folate receptor-mediated tumor detection as a triage tool in cervical cancer screening.
    Int J Gynaecol Obstet. 2020 May 29. doi: 10.1002/ijgo.13245.
    PubMed     Abstract available


  48. PAINTER H, Erlinger A, Simon B, Morroni C, et al
    Impact of cervicitis on performance of cervical cancer screening using HRHPV testing and visual evaluation in women living with HIV in Botswana.
    Int J Gynaecol Obstet. 2020 May 25. doi: 10.1002/ijgo.13235.
    PubMed     Abstract available


  49. BULE YP, Silva J, Carrilho C, Campos C, et al
    Human papillomavirus prevalence and distribution in self-collected samples from female university students in Maputo.
    Int J Gynaecol Obstet. 2020;149:237-246.
    PubMed     Abstract available


    April 2020
  50. MUNGO C, Ibrahim S, Bukusi EA, Truong HM, et al
    Scaling up cervical cancer prevention in Western Kenya: Treatment access following a community-based HPV testing approach.
    Int J Gynaecol Obstet. 2020 Apr 29. doi: 10.1002/ijgo.13171.
    PubMed     Abstract available


  51. MCCLYMONT E, Lee M, Raboud J, Coutlee F, et al
    Prevalent and persistent oncogenic HPV types in a cohort of women living with HIV prior to HPV vaccination.
    Int J Gynaecol Obstet. 2020 Apr 27. doi: 10.1002/ijgo.13185.
    PubMed     Abstract available



  52. FIGO statement on minimally invasive surgery in cervical cancer.
    Int J Gynaecol Obstet. 2020 Apr 17. doi: 10.1002/ijgo.13141.
    PubMed    


  53. AKILLI H, Tohma YA, Bulut AN, Atasoy Karakas L, et al
    Comparison of no adjuvant treatment and radiotherapy in early-stage cervical carcinoma with intermediate risk factors.
    Int J Gynaecol Obstet. 2020 Apr 4. doi: 10.1002/ijgo.13147.
    PubMed     Abstract available


  54. KEHOE S, Bhatla N
    FIGO stage IIB cervical cancer prognostication in low-resource settings.
    Int J Gynaecol Obstet. 2020 Apr 3. doi: 10.1002/ijgo.13138.
    PubMed    


    February 2020
  55. TIMOTEO-LIAINA I, Khozaim K, Chen YA, Buenconsejo-Lum L, et al
    The rising relative and absolute incidence of uterine cancer in specific populations.
    Int J Gynaecol Obstet. 2020 Feb 29. doi: 10.1002/ijgo.13130.
    PubMed     Abstract available


  56. SUMMERS G, Tierney B, Crotzer D
    Survival outcomes of minimally invasive versus open radical hysterectomy for low-risk, early-stage cervical cancer.
    Int J Gynaecol Obstet. 2020 Feb 19. doi: 10.1002/ijgo.13122.
    PubMed     Abstract available


  57. LAWAL IK, Ibrahim Abdullahi H, Obiokwonkwo AC
    Revised (2018) FIGO stage IIB cervical cancer and prognostication in low-resource settings.
    Int J Gynaecol Obstet. 2020 Feb 13. doi: 10.1002/ijgo.13120.
    PubMed     Abstract available


  58. KURIAKOSE S, Sabeena S, Binesh D, Abdulmajeed J, et al
    Diagnostic accuracy of self-collected vaginal samples for HPV DNA detection in women from South India.
    Int J Gynaecol Obstet. 2020 Feb 9. doi: 10.1002/ijgo.13116.
    PubMed     Abstract available


  59. NODJIKOUAMBAYE ZA, Adawaye C, Bouassa RM, Sadjoli D, et al
    A systematic review of self-sampling for HPV testing in Africa.
    Int J Gynaecol Obstet. 2020 Feb 9. doi: 10.1002/ijgo.13112.
    PubMed     Abstract available


    January 2020
  60. ADANU RMK
    Eradicating cervical cancer.
    Int J Gynaecol Obstet. 2020;148:1-2.
    PubMed    


    December 2019
  61. HUCHKO MJ, Olwanda E, Choi Y, Kahn JG, et al
    HPV-based cervical cancer screening in low-resource settings: Maximizing the efficiency of community-based strategies in rural Kenya.
    Int J Gynaecol Obstet. 2019 Dec 17. doi: 10.1002/ijgo.13090.
    PubMed     Abstract available


  62. LARA-PENARANDA R, Rodriguez-Lopez PM, Plitt-Stevens J, Ortiz-Gonzalez A, et al
    Does the trend toward less deep excisions in LLETZ to minimize obstetric risk lead to less favorable oncological outcomes?
    Int J Gynaecol Obstet. 2019 Dec 8. doi: 10.1002/ijgo.13080.
    PubMed     Abstract available


    November 2019
  63. DAYAL U, Gupta B, Hariprasad R, Shriya R, et al
    Comparison of the AV Magnivisualizer device with colposcopy to detect cervical intraepithelial neoplasia using the Swede scoring system.
    Int J Gynaecol Obstet. 2019;147:219-224.
    PubMed     Abstract available


    October 2019
  64. PETER IM, Deraney RN, Orango O, Philip T, et al
    Radical hysterectomy for operable early cervical cancer in HIV-positive and HIV-negative women in western Kenya.
    Int J Gynaecol Obstet. 2019 Oct 19. doi: 10.1002/ijgo.13004.
    PubMed     Abstract available


  65. DE FOUW M, Oosting RM, Rutgrink A, Dekkers OM, et al
    A systematic review and meta-analysis of thermal coagulation compared with cryotherapy to treat precancerous cervical lesions in low- and middle-income countries.
    Int J Gynaecol Obstet. 2019;147:4-18.
    PubMed     Abstract available


    September 2019
  66. KOHLER RE, Elliott T, Monare B, Moshashane N, et al
    HPV self-sampling acceptability and preferences among women living with HIV in Botswana.
    Int J Gynaecol Obstet. 2019 Sep 5. doi: 10.1002/ijgo.12963.
    PubMed     Abstract available


  67. BONI S, Tchounga B, Comoe K, Guie P, et al
    Assessment of the scale-up of cervical cancer screening in Abidjan stratified by HIV status.
    Int J Gynaecol Obstet. 2019 Sep 4. doi: 10.1002/ijgo.12959.
    PubMed     Abstract available


    July 2019
  68. BOGANI G, Serati M, Maggiore ULR, Ditto A, et al
    Cervical intraepithelial neoplasia in women who had vaccination against HPV.
    Int J Gynaecol Obstet. 2019 Jul 30. doi: 10.1002/ijgo.12934.
    PubMed     Abstract available


  69. MIRALPEIX E, Sole-Sedeno JM, Agramunt S, Lloveras B, et al
    Role of Chlamydia trachomatis serology in conservative management of cervical intraepithelial neoplasia grade 2.
    Int J Gynaecol Obstet. 2019 Jul 4. doi: 10.1002/ijgo.12903.
    PubMed     Abstract available


    June 2019
  70. SONG J, Chen W, Zhu X, Zhao Z, et al
    Short-term efficacy, safety, and cost-effectiveness of transarterial chemoembolization with drug-eluting beads versus synchronous radiochemotherapy for cervical cancer.
    Int J Gynaecol Obstet. 2019 Jun 17. doi: 10.1002/ijgo.12888.
    PubMed     Abstract available


    May 2019
  71. OBERLIN AM, Pasipamire T, Chibwesha CJ
    Exploring women's preferences for HPV-based cervical cancer screening in South Africa.
    Int J Gynaecol Obstet. 2019 May 25. doi: 10.1002/ijgo.12869.
    PubMed     Abstract available


  72. ADSUL P, Srinivas V, Gowda S, Nayaka S, et al
    A community-based, cross-sectional study of hrHPV DNA self-sampling-based cervical cancer screening in rural Karnataka, India.
    Int J Gynaecol Obstet. 2019 May 10. doi: 10.1002/ijgo.12859.
    PubMed     Abstract available


    April 2019
  73. BHATLA N, Berek JS, Cuello Fredes M, Denny LA, et al
    Revised FIGO staging for carcinoma of the cervix uteri.
    Int J Gynaecol Obstet. 2019;145:129-135.
    PubMed     Abstract available


    March 2019
  74. CHEN C, Zhang W, Liu P, Su G, et al
    Discrepancies between clinical staging and surgicopathologic findings in early-stage cervical cancer and prognostic significance.
    Int J Gynaecol Obstet. 2019 Mar 22. doi: 10.1002/ijgo.12807.
    PubMed     Abstract available


    January 2019
  75. CAMPOS NG, Maza M, Alfaro K, Gage JC, et al
    The cost-effectiveness of implementing HPV testing for cervical cancer screening in El Salvador.
    Int J Gynaecol Obstet. 2019 Jan 31. doi: 10.1002/ijgo.12773.
    PubMed     Abstract available


    December 2018
  76. KAPAMBWE S, Mwanahamuntu M, Pinder LF, Chisele S, et al
    Partnering with traditional Chiefs to expand access to cervical cancer prevention services in rural Zambia.
    Int J Gynaecol Obstet. 2018 Dec 23. doi: 10.1002/ijgo.12750.
    PubMed     Abstract available


  77. CHEN M, Cai H, Chen S, Wu X, et al
    Comparative analysis of transcervical resection and loop electrosurgical excision in the treatment of high-grade cervical intraepithelial neoplasia.
    Int J Gynaecol Obstet. 2018;143:306-312.
    PubMed     Abstract available


    October 2018
  78. RISLEY C, Geisinger KR, Robinson JC, Stewart MW, et al
    Precancerous cervical lesions and HPV genotypes identified in previously unsatisfactory cervical smear tests after inexpensive glacial acetic acid processing.
    Int J Gynaecol Obstet. 2018 Oct 26. doi: 10.1002/ijgo.12699.
    PubMed     Abstract available


  79. BOTHA MH, Rajaram S, Karunaratne K
    Cancer in pregnancy.
    Int J Gynaecol Obstet. 2018;143 Suppl 2:137-142.
    PubMed     Abstract available


  80. BHATLA N, Aoki D, Sharma DN, Sankaranarayanan R, et al
    Cancer of the cervix uteri.
    Int J Gynaecol Obstet. 2018;143 Suppl 2:22-36.
    PubMed     Abstract available


  81. XAVIER-JUNIOR JCC, Camilo-Junior DJ, Gardini APHGDA, D'avilla SCGP, et al
    Association between high-grade squamous intraepithelial lesion, age, and number and interval of smears in women in Aracatuba, Brazil.
    Int J Gynaecol Obstet. 2018;143:110-111.
    PubMed    


    September 2018
  82. RASUL VH, Moghdam ZB, Karim MA, Cheraghi MA, et al
    Challenges in delivery and performance of a cervical cancer prevention program in the Kurdistan Region of the Iraq health system.
    Int J Gynaecol Obstet. 2018 Sep 21. doi: 10.1002/ijgo.12684.
    PubMed     Abstract available


    August 2018
  83. OBERLIN AM, Rahangdale L, Chinula L, Fuseini NM, et al
    Making HPV vaccination available to girls everywhere.
    Int J Gynaecol Obstet. 2018 Aug 24. doi: 10.1002/ijgo.12656.
    PubMed     Abstract available


  84. YALCIN I, Sari ME, Sahin H, Gultekin M, et al
    Colposcopic biopsy findings among women with either HPV-16 only or HPV-18 only who have normal cervical cytology.
    Int J Gynaecol Obstet. 2018 Aug 20. doi: 10.1002/ijgo.12652.
    PubMed     Abstract available


    July 2018
  85. ROURA-MONLLOR J, Nieves-Munoz J, Ortiz AP, Romaguera J, et al
    HPV knowledge, vaccine knowledge, and vaccine acceptance in women with cervical cytology anomalies attending colposcopy clinics in Puerto Rico.
    Int J Gynaecol Obstet. 2018 Jul 10. doi: 10.1002/ijgo.12594.
    PubMed     Abstract available


    June 2018
  86. ROBLES C, Wiesner C, Martinez S, Salgado Y, et al
    Impact of operational factors on HPV positivity rates in an HPV-based screening study in Colombia.
    Int J Gynaecol Obstet. 2018 Jun 26. doi: 10.1002/ijgo.12574.
    PubMed     Abstract available


  87. BOGANI G, Taverna F, Lombardo C, Signorelli M, et al
    Potential impact of introducing a nonavalent HPV vaccination.
    Int J Gynaecol Obstet. 2018 Jun 2. doi: 10.1002/ijgo.12546.
    PubMed     Abstract available


  88. NING L, Zhang W, Yang J, Cao D, et al
    Prognostic factors of FIGO stage I-IIA small-cell neuroendocrine carcinoma of the uterine cervix.
    Int J Gynaecol Obstet. 2018 Jun 2. doi: 10.1002/ijgo.12544.
    PubMed     Abstract available


  89. BERGENGREN L, Kaliff M, L Larsson G, Karlsson MG, et al
    Comparison between professional sampling and self-sampling for HPV-based cervical cancer screening among postmenopausal women.
    Int J Gynaecol Obstet. 2018 Jun 1. doi: 10.1002/ijgo.12538.
    PubMed     Abstract available


  90. CUELLO MA, Espinosa ME, Orlandini EJ, Hwang DY, et al
    The value of endocervical curettage during loop electrosurgical excision procedures in predicting persistent/recurrent preinvasive cervical disease.
    Int J Gynaecol Obstet. 2018;141:337-343.
    PubMed     Abstract available


  91. JUNTASOPEEPUN P, Thana K
    Parental acceptance of HPV vaccines in Chiang Mai, Thailand.
    Int J Gynaecol Obstet. 2018 Jun 1. doi: 10.1002/ijgo.12539.
    PubMed     Abstract available


    May 2018
  92. DRISCOLL SD, Tappen RM, Newman D, Voege-Harvey K, et al
    Accuracy of visual inspection performed by community health workers in cervical cancer screening.
    Int J Gynaecol Obstet. 2018 May 22. doi: 10.1002/ijgo.12535.
    PubMed     Abstract available


  93. MICHAAN N, Gortzak-Uzan L, Grisario D, Laskov I, et al
    Ethnicity-related trends in gynecologic malignancies in Israel, 1993-2013.
    Int J Gynaecol Obstet. 2018 May 9. doi: 10.1002/ijgo.12524.
    PubMed     Abstract available


    February 2018
  94. HERACLIO SA, de Souza ASR, de Souza PRE, Katz L, et al
    Cross-sectional study of anal intraepithelial lesions in women with cervical neoplasia without HIV.
    Int J Gynaecol Obstet. 2018;140:233-240.
    PubMed     Abstract available


  95. HAKEM E, Ibrahim E, Tanyous E, Astbury K, et al
    Association between grade of referral smear and high-grade disease among women with biopsy samples showing cervical intraepithelial neoplasia grade 2.
    Int J Gynaecol Obstet. 2018;140:223-227.
    PubMed     Abstract available


    January 2018
  96. MAGED AM, Saad H, Salah E, Meshaal H, et al
    Urine test for HPV genotypes as a predictor of precancerous cervical lesions and for cervical cancer screening.
    Int J Gynaecol Obstet. 2018 Jan 31. doi: 10.1002/ijgo.12453.
    PubMed     Abstract available


    December 2017
  97. RIZZUTO I, Nalam M, Jiang J, Linder A, et al
    Risk factors for HPV persistence and cytology anomalies at follow-up after treatment for cervical dysplasia.
    Int J Gynaecol Obstet. 2017 Dec 17. doi: 10.1002/ijgo.12431.
    PubMed     Abstract available


  98. HUCHKO MJ, Ibrahim S, Blat C, Cohen CR, et al
    Cervical cancer screening through human papillomavirus testing in community health campaigns versus health facilities in rural western Kenya.
    Int J Gynaecol Obstet. 2017 Dec 2. doi: 10.1002/ijgo.12415.
    PubMed     Abstract available


    August 2017
  99. ZHANG X, Ding J, Tao X, Qian H, et al
    Diagnosis and treatment of cervical papillary squamous cell carcinoma with unknown depth of stromal invasion.
    Int J Gynaecol Obstet. 2017;138:190-193.
    PubMed     Abstract available


    July 2017
  100. MABUCHI S, Kozasa K, Kimura T
    Radical hysterectomy after radiotherapy for recurrent or persistent cervical cancer.
    Int J Gynaecol Obstet. 2017 Jul 28. doi: 10.1002/ijgo.12284.
    PubMed     Abstract available


  101. OGILVIE G, Nakisige C, Huh WK, Mehrotra R, et al
    Optimizing secondary prevention of cervical cancer: Recent advances and future challenges.
    Int J Gynaecol Obstet. 2017;138 Suppl 1:15-19.
    PubMed     Abstract available


  102. WHITE HL, Meglioli A, Chowdhury R, Nuccio O, et al
    Integrating cervical cancer screening and preventive treatment with family planning and HIV-related services.
    Int J Gynaecol Obstet. 2017;138 Suppl 1:41-46.
    PubMed     Abstract available


  103. BASU P, Meheus F, Chami Y, Hariprasad R, et al
    Management algorithms for cervical cancer screening and precancer treatment for resource-limited settings.
    Int J Gynaecol Obstet. 2017;138 Suppl 1:26-32.
    PubMed     Abstract available


  104. TSU VD
    Cervical cancer prevention for all women: Why now?
    Int J Gynaecol Obstet. 2017;138 Suppl 1:1-3.
    PubMed    


  105. CAMPOS NG, Sharma M, Clark A, Lee K, et al
    The health and economic impact of scaling cervical cancer prevention in 50 low- and lower-middle-income countries.
    Int J Gynaecol Obstet. 2017;138 Suppl 1:47-56.
    PubMed     Abstract available


  106. WITTET S, Aylward J, Cowal S, Drope J, et al
    Advocacy, communication, and partnerships: Mobilizing for effective, widespread cervical cancer prevention.
    Int J Gynaecol Obstet. 2017;138 Suppl 1:57-62.
    PubMed     Abstract available


  107. HOLME F, Kapambwe S, Nessa A, Basu P, et al
    Scaling up proven innovative cervical cancer screening strategies: Challenges and opportunities in implementation at the population level in low- and lower-middle-income countries.
    Int J Gynaecol Obstet. 2017;138 Suppl 1:63-68.
    PubMed     Abstract available


  108. DRUMMOND JL, Were MC, Arrossi S, Wools-Kaloustian K, et al
    Cervical cancer data and data systems in limited-resource settings: Challenges and opportunities.
    Int J Gynaecol Obstet. 2017;138 Suppl 1:33-40.
    PubMed     Abstract available


  109. TSU VD, Ginsburg O
    The investment case for cervical cancer elimination.
    Int J Gynaecol Obstet. 2017;138 Suppl 1:69-73.
    PubMed     Abstract available


  110. ARANDA S, Berkley S, Cowal S, Dybul M, et al
    Ending cervical cancer: A call to action.
    Int J Gynaecol Obstet. 2017;138 Suppl 1:4-6.
    PubMed     Abstract available


  111. CASTLE PE, Murokora D, Perez C, Alvarez M, et al
    Treatment of cervical intraepithelial lesions.
    Int J Gynaecol Obstet. 2017;138 Suppl 1:20-25.
    PubMed     Abstract available


  112. LAMONTAGNE DS, Bloem PJN, Brotherton JML, Gallagher KE, et al
    Progress in HPV vaccination in low- and lower-middle-income countries.
    Int J Gynaecol Obstet. 2017;138 Suppl 1:7-14.
    PubMed     Abstract available


    June 2017
  113. PISTA A, de Oliveira CF, Lopes C, Cunha MJ, et al
    Potential impact of nonavalent HPV vaccine in the prevention of high-grade cervical lesions and cervical cancer in Portugal.
    Int J Gynaecol Obstet. 2017 Jun 20. doi: 10.1002/ijgo.12243.
    PubMed     Abstract available


  114. LASKOW B, Figueroa R, Alfaro KM, Scarinci IC, et al
    A pilot study of community-based self-sampling for HPV testing among non-attenders of cervical cancer screening programs in El Salvador.
    Int J Gynaecol Obstet. 2017 Jun 7. doi: 10.1002/ijgo.12204.
    PubMed     Abstract available


  115. CHIGBU CO, Onyebuchi AK, Onyeka TC, Odugu BU, et al
    The impact of community health educators on uptake of cervical and breast cancer prevention services in Nigeria.
    Int J Gynaecol Obstet. 2017;137:319-324.
    PubMed     Abstract available


    May 2017
  116. HAN Y, Li N, Zhang R, Li X, et al
    Role of positive peritoneal cytology in FIGO stage IB to IIB cervical adenocarcinoma.
    Int J Gynaecol Obstet. 2017;137:150-156.
    PubMed     Abstract available


    April 2017
  117. KONERU A, Jolly PE, Blakemore S, McCree R, et al
    Acceptance of peer navigators to reduce barriers to cervical cancer screening and treatment among women with HIV infection in Tanzania.
    Int J Gynaecol Obstet. 2017 Apr 8. doi: 10.1002/ijgo.12174.
    PubMed     Abstract available


    February 2017
  118. PATEL H, Pcolkina K, Strazdina K, Viberga I, et al
    Awareness of HPV infection and attitudes toward HPV vaccination among Latvian adolescents.
    Int J Gynaecol Obstet. 2017 Feb 7. doi: 10.1002/ijgo.12117.
    PubMed     Abstract available


  119. GONZALEZ-BOSQUET E, Fernandez S, Sabra S, Lailla JM, et al
    Negative HPV testing among patients with biopsy-proven cervical intraepithelial neoplasia grade 2/3 or cervical cancer.
    Int J Gynaecol Obstet. 2017;136:229-231.
    PubMed     Abstract available


  120. VODICKA EL, Babigumira JB, Mann MR, Kosgei RJ, et al
    Costs of integrating cervical cancer screening at an HIV clinic in Kenya.
    Int J Gynaecol Obstet. 2017;136:220-228.
    PubMed     Abstract available


    January 2017
  121. GIANNELLA L, Fodero C, Boselli F, Rubino T, et al
    Age-related changes in pre- and post-conization HPV genotype distribution among women with high-grade cervical intraepithelial neoplasia.
    Int J Gynaecol Obstet. 2017 Jan 27. doi: 10.1002/ijgo.12106.
    PubMed     Abstract available


  122. FIGUEROA-DOWNING D, Baggio ML, Baker ML, Dias De Oliveira Chiang E, et al
    Factors influencing HPV vaccine delivery by healthcare professionals at public health posts in Sao Paulo, Brazil.
    Int J Gynaecol Obstet. 2017;136:33-39.
    PubMed     Abstract available


  123. ZHANG G, Lang J, Shen K, Zhu L, et al
    High-risk human papillomavirus infection clearance following conization among patients with cervical intraepithelial neoplasm grade 3 aged at least 45 years.
    Int J Gynaecol Obstet. 2017;136:47-52.
    PubMed     Abstract available


  124. FAJARDO-RAMIREZ OR, Barboza-Cerda MC, Ortiz-Lopez R, Rojas-Martinez A, et al
    Prevalence and 3-year persistence of human papillomavirus serotypes in asymptomatic patients in Northern Mexico.
    Int J Gynaecol Obstet. 2017;136:40-46.
    PubMed     Abstract available


    December 2016
  125. MARIANI L, Preti M, Cristoforoni P, Stigliano CM, et al
    Overview of the benefits and potential issues of the nonavalent HPV vaccine.
    Int J Gynaecol Obstet. 2016 Dec 7. doi: 10.1002/ijgo.12075.
    PubMed     Abstract available


    November 2016
  126. COMPARETTO C, Epifani C, Manca MC, Lachheb A, et al
    Uptake of cervical cancer screening among the migrant population of Prato Province, Italy.
    Int J Gynaecol Obstet. 2016 Nov 25. doi: 10.1002/ijgo.12067.
    PubMed     Abstract available


  127. MARIANI L, Igidbashian S, Sandri MT, Vici P, et al
    The clinical implementation of primary HPV screening.
    Int J Gynaecol Obstet. 2016 Nov 21. doi: 10.1002/ijgo.12065.
    PubMed     Abstract available


    July 2016
  128. MIYAMOTO S, Hasegawa J, Morioka M, Hirota Y, et al
    The association between p16 and Ki-67 immunohistostaining and the progression of cervical intraepithelial neoplasia grade 2.
    Int J Gynaecol Obstet. 2016;134:45-8.
    PubMed     Abstract available


  129. NEGULESCU RA, Catarino R, De Vuyst H, Undurraga-Malinverno M, et al
    Web-based instrument to assess skills in visual inspection of the cervix among healthcare providers.
    Int J Gynaecol Obstet. 2016;134:107-13.
    PubMed     Abstract available


  130. BOONLIKIT S
    Performance of the abbreviated Reid colposcopic index in prediction of high-grade lesions.
    Int J Gynaecol Obstet. 2016;134:41-4.
    PubMed     Abstract available


    June 2016
  131. NAUD PS, Muwonge R, Passos EP, Magno V, et al
    Efficacy, safety, and acceptability of thermocoagulation for treatment of cervical intraepithelial neoplasia in a hospital setting in Brazil.
    Int J Gynaecol Obstet. 2016;133:351-4.
    PubMed     Abstract available


    March 2016
  132. SANTESSO N, Mustafa RA, Wiercioch W, Kehar R, et al
    Systematic reviews and meta-analyses of benefits and harms of cryotherapy, LEEP, and cold knife conization to treat cervical intraepithelial neoplasia.
    Int J Gynaecol Obstet. 2016;132:266-71.
    PubMed     Abstract available


    February 2016
  133. MOEIN S, Mohajer R
    Fluorescein sodium as a contrast agent for colposcopy.
    Int J Gynaecol Obstet. 2016;132:238-9.
    PubMed    


    November 2015
  134. MUSTAFA RA, Santesso N, Khatib R, Mustafa AA, et al
    Systematic reviews and meta-analyses of the accuracy of HPV tests, visual inspection with acetic acid, cytology, and colposcopy.
    Int J Gynaecol Obstet. 2015 Nov 12. pii: S0020-7292(15)00663.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: